Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
about
Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB)Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral LeishmaniasisEfficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.The Syrian conflict and infectious diseases.Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.
P2860
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@ast
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@en
type
label
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@ast
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@en
prefLabel
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@ast
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@en
P2093
P2860
P1476
Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers
@en
P2093
Daniel P Eiras
Henry W Murray
Laura A Kirkman
P2860
P2888
P356
10.1007/S40506-015-0038-4
P577
2015-03-01T00:00:00Z